SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings

Bansal, Deepak and Davidson, Alan and Supriyadi, Eddy and Njuguna, Festus and Ribeiro, Raul C. and Kaspers, Gertjan J. L. (2023) SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings. Pediatric Blood and Cancer, 70 (11): e28087. ISSN 15455009

[thumbnail of SIOP PODC adapted risk stratification and treatment guidelines.pdf] Text
SIOP PODC adapted risk stratification and treatment guidelines.pdf - Published Version
Restricted to Registered users only
Available under License Creative Commons Attribution.

Download (754kB) | Request a copy

Abstract

In low- and middle-income countries (LMICs), limited resources, suboptimal risk stratification, and disproportionate patient-to-infrastructure ratio result in low survival of patients with acute myeloid leukemia (AML). A high incidence of relapse, inherent to the biology, renders management arduous. The challenge of treating AML in LMICs is of balancing the intensity of myelosuppressive chemotherapy, which appears necessary for cure, with available supportive care, which influences treatment-related mortality. The recommendations outlined in this paper are based on published evidence and expert opinion. The principle of this adapted protocol is to tailor treatment to available resources, reduce preventable toxic death, and direct limited resources toward those children who are most likely to be cured. © 2019 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals, Inc.

Item Type: Article
Additional Information: Cited by: 13; All Open Access, Hybrid Gold Open Access
Uncontrolled Keywords: Child; Humans; Leukemia, Myeloid, Acute; Recurrence; Resource-Limited Settings; Risk Assessment; antileukemic agent; cytarabine; cytarabine plus daunorubicin; etoposide; granulocyte colony stimulating factor; acute myeloid leukemia; adaptation; antineoplastic protocol; Article; blood cell count; bone marrow examination; cancer chemotherapy; cancer diagnosis; cancer palliative therapy; cancer prevention; cancer therapy; central nervous system disease; consolidation chemotherapy; Down syndrome; drug megadose; human; hyperleucocytosis; induction chemotherapy; leukemia relapse; leukocytosis; patient monitoring; practice guideline; promyelocytic leukemia; risk; single drug dose; supportive care need; tumor lysis syndrome; acute myeloid leukemia; child; recurrent disease; resource limited setting; risk assessment
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Depositing User: Ani PURWANDARI
Date Deposited: 27 May 2024 08:36
Last Modified: 27 May 2024 08:36
URI: https://ir.lib.ugm.ac.id/id/eprint/1152

Actions (login required)

View Item
View Item